Keywords: fda, approves, b-ms, orencia, jia, drug, major

FDA approves B-MS' Orencia for JIA

Article | 14 April 2008

Print This

US drug major Bristol-Myers Squibb says that the Food and Drug Administration has approved Orencia (abatacept) for reducing signs and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in